Targeting PPM1D by lentivirus-mediated RNA interference inhibits the tumorigenicity of bladder cancer cells

被引:14
作者
Wang, W. [1 ,3 ]
Zhu, H. [3 ]
Zhang, H. [2 ]
Zhang, L. [2 ]
Ding, Q. [1 ,2 ]
Jiang, H. [1 ,2 ]
机构
[1] Fudan Univ, Huashan Hosp, Inst Urol, Shanghai 200040, Peoples R China
[2] Fudan Univ, Huashan Hosp, Dept Urol, Shanghai 200040, Peoples R China
[3] Fudan Univ, Huashan Hosp, Dept Intens Care Unit, Shanghai 200040, Peoples R China
基金
中国国家自然科学基金;
关键词
Protein phosphatase magnesium/manganese-dependent 1D; Bladder cancer; Gene silencing; RNA interference; Proliferation; WIP1; PHOSPHATASE; PROTEIN PHOSPHATASE; TUMOR-SUPPRESSOR; P53; PROLIFERATION; PATHWAY; THERAPEUTICS; ACTIVATION; STRATEGIES; BREAST;
D O I
10.1590/1414-431X20143645
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Protein phosphatase magnesium/manganese-dependent 1D (PPM1D) is a p53-induced phosphatase that functions as a negative regulator of stress response pathways and has oncogenic properties. However, the functional role of PPM1D in bladder cancer (BC) remains largely unknown. In the present study, lentivirus vectors carrying small hairpin RNA (shRNA) targeting PPM1D were used to explore the effects of PPM1D knockdown on BC cell proliferation and tumorigenesis. shRNA-mediated knockdown of PPM1D significantly inhibited cell growth and colony forming ability in the BC cell lines 5637 and T24. Flow cytometric analysis showed that PPM1D silencing increased the proportion of cells in the G0/G1 phase. Downregulation of PPM1D also inhibited 5637 cell tumorigenicity in nude mice. The results of the present study suggest that PPM1D plays a potentially important role in BC tumorigenicity, and lentivirus-mediated delivery of shRNA against PPM1D might be a promising therapeutic strategy for the treatment of BC.
引用
收藏
页码:1044 / 1049
页数:6
相关论文
共 30 条
[1]   The oncogenic phosphatase PPM1D confers cisplatin resistance in ovarian carcinoma cells by attenuating checkpoint kinase 1 and p53 activation [J].
Ali, A. Y. ;
Abedini, M. R. ;
Tsang, B. K. .
ONCOGENE, 2012, 31 (17) :2175-2186
[2]   RNA interference therapeutics for cancer: Challenges and opportunities (Review) [J].
Bora, Roop Singh ;
Gupta, Dikshi ;
Mukkur, Trilochan Kanwaljit Singh ;
Saini, Kulvinder Singh .
MOLECULAR MEDICINE REPORTS, 2012, 6 (01) :9-15
[3]   Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16Ink4a-p19Arf pathway [J].
Bulavin, DV ;
Phillips, C ;
Nannenga, B ;
Timofeev, O ;
Donehower, LA ;
Anderson, CW ;
Appella, E ;
Fornace, AJ .
NATURE GENETICS, 2004, 36 (04) :343-350
[4]   Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity [J].
Bulavin, DV ;
Demidov, ON ;
Saito, S ;
Kauraniemi, P ;
Phillips, C ;
Amundson, SA ;
Ambrosino, C ;
Sauter, G ;
Nebreda, AR ;
Anderson, CW ;
Kallioniemi, A ;
Fornace, AJ ;
Appella, E .
NATURE GENETICS, 2002, 31 (02) :210-215
[5]   The promises and pitfalls of RNA-interference-based therapeutics [J].
Castanotto, Daniela ;
Rossi, John J. .
NATURE, 2009, 457 (7228) :426-433
[6]   The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis [J].
Demidov, O. N. ;
Kek, C. ;
Shreeram, S. ;
Timofeev, O. ;
Fornace, A. J. ;
Appella, E. ;
Bulavin, D. V. .
ONCOGENE, 2007, 26 (17) :2502-2506
[7]   DNA damage signaling induced by the G-quadruplex ligand 12459 is modulated by PPM1D/WIP1 phosphatase [J].
Douarre, Celine ;
Mergui, Xenia ;
Sidibe, Assitan ;
Gomez, Dennis ;
Alberti, Patrizia ;
Mailliet, Patrick ;
Trentesaux, Chantal ;
Riou, Jean-Francois .
NUCLEIC ACIDS RESEARCH, 2013, 41 (06) :3588-3599
[8]   Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner [J].
Fiscella, M ;
Zhang, HL ;
Fan, SJ ;
Sakaguchi, K ;
Shen, SF ;
Mercer, WE ;
VandeWoude, GF ;
OConnor, PM ;
Appella, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (12) :6048-6053
[9]   Current status of molecular markers for prognostication and outcome in invasive bladder cancer [J].
Gakis, Georgios ;
Schwentner, Christian ;
Todenhoefer, Tilman ;
Stenzl, Arnulf .
BJU INTERNATIONAL, 2012, 110 (02) :233-237
[10]   Strategies to prevent progression of high-risk bladder cancer at initial diagnosis [J].
Ku, Ja H. ;
Lerner, Seth P. .
CURRENT OPINION IN UROLOGY, 2012, 22 (05) :405-414